Due to rapidly evolving regulatory landscape and manufacturing demands, label requirements and the information they contain are constantly changing. Here’s how medtech organizations can manage the process.
It’s important to draw on experience from other sectors.
The agency has realigned information technology, data management and cybersecurity functions, and established a new office reporting directly to the FDA commissioner.
To achieve success, a medical device startup must build a sophisticated data architecture specifically designed to deliver maximum value for its customers’ use cases. However, it’s extremely difficult to build such an architecture—especially given early-stage budget constraints. That’s why startups must wisely synch their data architecture spending with their funding rounds.
Increased awareness during the COVID-19 crisis and public efforts to strengthen the development of healthcare technologies has boosted the smart medical devices sector.
A look at the factors contributing to the slow adoption rate of these devices in the OR, along with how the industry can increase adoption.
U.S. companies are increasingly engaging with organizations worldwide to push innovation in nanotechnology forward.
The FDA requires medical device manufacturers to demonstrate the sterility of their products. Whether a device functions in vivo or in vitro, sterility is crucial to ensuring patient safety and maximizing device functionality.
Integration with advanced AI systems and a rapidly expanding application scope will position medical robots among the key solutions for efficient, accurate and safe healthcare service delivery.
The COVID-19 pandemic has changed hospital processes and made people more aware of the need to thoroughly sterilize medical instruments between patients. This article discusses some of the changes that may occur due to lessons learned throughout the global health emergency.